ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trigger Point Injections Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-30U18658
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Trigger Point Injections Drugs Market Research Report 2025
BUY CHAPTERS

Global Trigger Point Injections Drugs Market Research Report 2025

Code: QYRE-Auto-30U18658
Report
February 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Pfizer Inc
Hospira
Mylan NV
Bayer
Zimmer Biomet
Teva Pharmaceuticals
Bristol–Myers Squibb
Regeneron Pharmaceuticals
Boehringer Ingelheim
Ipsen S A
EUROAPI
GlaxoSmithKline PLC
Hovione
Axplora
Steroid S.p.A.
Sun Pharmaceutical
Cipla Ltd
Anuh Pharma
Symbiotec Pharmalab
GSK
Wellona Pharma

Trigger Point Injections Drugs Market Size

The global market for Trigger Point Injections Drugs was valued at US$ 12110 million in the year 2024 and is projected to reach a revised size of US$ 18010 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Trigger Point Injections Drugs Market

Trigger Point Injections Drugs Market

Trigger point injections (TPIs) are a treatment method used to alleviate pain and discomfort caused by muscle knots or myofascial pain syndrome. These knots, also called "trigger points," are tight, hyperirritable spots in skeletal muscle that can cause localized pain or referred pain in other areas of the body. Trigger point injections involve injecting a specific medication directly into the muscle or surrounding tissue at the site of the trigger point to relax the muscle and relieve pain.
North American market for Trigger Point Injections Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Trigger Point Injections Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Trigger Point Injections Drugs in Surgical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Trigger Point Injections Drugs include Allergan, Pfizer, Hospira, Mylan, Bayer, Zimmer Biomet, Teva Pharmaceuticals, Bristol Myers Squibb, Regeneron Pharmaceuticals, Boehringer Ingelheim, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Trigger Point Injections Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trigger Point Injections Drugs.
The Trigger Point Injections Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trigger Point Injections Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trigger Point Injections Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Trigger Point Injections Drugs Market Report

Report Metric Details
Report Name Trigger Point Injections Drugs Market
Accounted market size in year US$ 12110 million
Forecasted market size in 2031 US$ 18010 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Local Anesthetics
  • Corticosteroids
  • Botulinum Toxin (Botox)
  • Platelet-Rich Plasma (PRP)
  • Other Agents
Segment by Application
  • Surgical
  • Intensive Care Area (ICU)
  • Medical Diagnosis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Pfizer, Hospira, Mylan, Bayer, Zimmer Biomet, Teva Pharmaceuticals, Bristol Myers Squibb, Regeneron Pharmaceuticals, Boehringer Ingelheim, Ipsen, EUROAPI, GlaxoSmithKline, Hovione, Axplora, Steroid, Sun Pharmaceutical, Cipla, Anuh Pharma, Symbiotec Pharmalab, GSK, Wellona Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Trigger Point Injections Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Trigger Point Injections Drugs Market growing?

Ans: The Trigger Point Injections Drugs Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Trigger Point Injections Drugs Market size in 2031?

Ans: The Trigger Point Injections Drugs Market size in 2031 will be US$ 18010 million.

Who are the main players in the Trigger Point Injections Drugs Market report?

Ans: The main players in the Trigger Point Injections Drugs Market are Allergan, Pfizer, Hospira, Mylan, Bayer, Zimmer Biomet, Teva Pharmaceuticals, Bristol Myers Squibb, Regeneron Pharmaceuticals, Boehringer Ingelheim, Ipsen, EUROAPI, GlaxoSmithKline, Hovione, Axplora, Steroid, Sun Pharmaceutical, Cipla, Anuh Pharma, Symbiotec Pharmalab, GSK, Wellona Pharma

What are the Application segmentation covered in the Trigger Point Injections Drugs Market report?

Ans: The Applications covered in the Trigger Point Injections Drugs Market report are Surgical, Intensive Care Area (ICU), Medical Diagnosis

What are the Type segmentation covered in the Trigger Point Injections Drugs Market report?

Ans: The Types covered in the Trigger Point Injections Drugs Market report are Local Anesthetics, Corticosteroids, Botulinum Toxin (Botox), Platelet-Rich Plasma (PRP), Other Agents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Trigger Point Injections Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Local Anesthetics
1.2.3 Corticosteroids
1.2.4 Botulinum Toxin (Botox)
1.2.5 Platelet-Rich Plasma (PRP)
1.2.6 Other Agents
1.3 Market by Application
1.3.1 Global Trigger Point Injections Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Surgical
1.3.3 Intensive Care Area (ICU)
1.3.4 Medical Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Trigger Point Injections Drugs Market Perspective (2020-2031)
2.2 Global Trigger Point Injections Drugs Growth Trends by Region
2.2.1 Global Trigger Point Injections Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Trigger Point Injections Drugs Historic Market Size by Region (2020-2025)
2.2.3 Trigger Point Injections Drugs Forecasted Market Size by Region (2026-2031)
2.3 Trigger Point Injections Drugs Market Dynamics
2.3.1 Trigger Point Injections Drugs Industry Trends
2.3.2 Trigger Point Injections Drugs Market Drivers
2.3.3 Trigger Point Injections Drugs Market Challenges
2.3.4 Trigger Point Injections Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Trigger Point Injections Drugs Players by Revenue
3.1.1 Global Top Trigger Point Injections Drugs Players by Revenue (2020-2025)
3.1.2 Global Trigger Point Injections Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Trigger Point Injections Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Trigger Point Injections Drugs Revenue
3.4 Global Trigger Point Injections Drugs Market Concentration Ratio
3.4.1 Global Trigger Point Injections Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Trigger Point Injections Drugs Revenue in 2024
3.5 Global Key Players of Trigger Point Injections Drugs Head office and Area Served
3.6 Global Key Players of Trigger Point Injections Drugs, Product and Application
3.7 Global Key Players of Trigger Point Injections Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Trigger Point Injections Drugs Breakdown Data by Type
4.1 Global Trigger Point Injections Drugs Historic Market Size by Type (2020-2025)
4.2 Global Trigger Point Injections Drugs Forecasted Market Size by Type (2026-2031)
5 Trigger Point Injections Drugs Breakdown Data by Application
5.1 Global Trigger Point Injections Drugs Historic Market Size by Application (2020-2025)
5.2 Global Trigger Point Injections Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Trigger Point Injections Drugs Market Size (2020-2031)
6.2 North America Trigger Point Injections Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Trigger Point Injections Drugs Market Size by Country (2020-2025)
6.4 North America Trigger Point Injections Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Trigger Point Injections Drugs Market Size (2020-2031)
7.2 Europe Trigger Point Injections Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Trigger Point Injections Drugs Market Size by Country (2020-2025)
7.4 Europe Trigger Point Injections Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Trigger Point Injections Drugs Market Size (2020-2031)
8.2 Asia-Pacific Trigger Point Injections Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Trigger Point Injections Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Trigger Point Injections Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Trigger Point Injections Drugs Market Size (2020-2031)
9.2 Latin America Trigger Point Injections Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Trigger Point Injections Drugs Market Size by Country (2020-2025)
9.4 Latin America Trigger Point Injections Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Trigger Point Injections Drugs Market Size (2020-2031)
10.2 Middle East & Africa Trigger Point Injections Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Trigger Point Injections Drugs Introduction
11.1.4 Allergan Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.1.5 Allergan Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Trigger Point Injections Drugs Introduction
11.2.4 Pfizer Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Hospira
11.3.1 Hospira Company Details
11.3.2 Hospira Business Overview
11.3.3 Hospira Trigger Point Injections Drugs Introduction
11.3.4 Hospira Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.3.5 Hospira Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Trigger Point Injections Drugs Introduction
11.4.4 Mylan Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.4.5 Mylan Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Trigger Point Injections Drugs Introduction
11.5.4 Bayer Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Zimmer Biomet
11.6.1 Zimmer Biomet Company Details
11.6.2 Zimmer Biomet Business Overview
11.6.3 Zimmer Biomet Trigger Point Injections Drugs Introduction
11.6.4 Zimmer Biomet Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.6.5 Zimmer Biomet Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Trigger Point Injections Drugs Introduction
11.7.4 Teva Pharmaceuticals Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb Trigger Point Injections Drugs Introduction
11.8.4 Bristol Myers Squibb Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.8.5 Bristol Myers Squibb Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Trigger Point Injections Drugs Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.9.5 Regeneron Pharmaceuticals Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Details
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Trigger Point Injections Drugs Introduction
11.10.4 Boehringer Ingelheim Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Ipsen
11.11.1 Ipsen Company Details
11.11.2 Ipsen Business Overview
11.11.3 Ipsen Trigger Point Injections Drugs Introduction
11.11.4 Ipsen Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.11.5 Ipsen Recent Development
11.12 EUROAPI
11.12.1 EUROAPI Company Details
11.12.2 EUROAPI Business Overview
11.12.3 EUROAPI Trigger Point Injections Drugs Introduction
11.12.4 EUROAPI Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.12.5 EUROAPI Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Trigger Point Injections Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Hovione
11.14.1 Hovione Company Details
11.14.2 Hovione Business Overview
11.14.3 Hovione Trigger Point Injections Drugs Introduction
11.14.4 Hovione Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.14.5 Hovione Recent Development
11.15 Axplora
11.15.1 Axplora Company Details
11.15.2 Axplora Business Overview
11.15.3 Axplora Trigger Point Injections Drugs Introduction
11.15.4 Axplora Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.15.5 Axplora Recent Development
11.16 Steroid
11.16.1 Steroid Company Details
11.16.2 Steroid Business Overview
11.16.3 Steroid Trigger Point Injections Drugs Introduction
11.16.4 Steroid Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.16.5 Steroid Recent Development
11.17 Sun Pharmaceutical
11.17.1 Sun Pharmaceutical Company Details
11.17.2 Sun Pharmaceutical Business Overview
11.17.3 Sun Pharmaceutical Trigger Point Injections Drugs Introduction
11.17.4 Sun Pharmaceutical Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.17.5 Sun Pharmaceutical Recent Development
11.18 Cipla
11.18.1 Cipla Company Details
11.18.2 Cipla Business Overview
11.18.3 Cipla Trigger Point Injections Drugs Introduction
11.18.4 Cipla Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.18.5 Cipla Recent Development
11.19 Anuh Pharma
11.19.1 Anuh Pharma Company Details
11.19.2 Anuh Pharma Business Overview
11.19.3 Anuh Pharma Trigger Point Injections Drugs Introduction
11.19.4 Anuh Pharma Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.19.5 Anuh Pharma Recent Development
11.20 Symbiotec Pharmalab
11.20.1 Symbiotec Pharmalab Company Details
11.20.2 Symbiotec Pharmalab Business Overview
11.20.3 Symbiotec Pharmalab Trigger Point Injections Drugs Introduction
11.20.4 Symbiotec Pharmalab Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.20.5 Symbiotec Pharmalab Recent Development
11.21 GSK
11.21.1 GSK Company Details
11.21.2 GSK Business Overview
11.21.3 GSK Trigger Point Injections Drugs Introduction
11.21.4 GSK Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.21.5 GSK Recent Development
11.22 Wellona Pharma
11.22.1 Wellona Pharma Company Details
11.22.2 Wellona Pharma Business Overview
11.22.3 Wellona Pharma Trigger Point Injections Drugs Introduction
11.22.4 Wellona Pharma Revenue in Trigger Point Injections Drugs Business (2020-2025)
11.22.5 Wellona Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Allergan plc
Pfizer Inc
Hospira
Mylan NV
Bayer
Zimmer Biomet
Teva Pharmaceuticals
Bristol–Myers Squibb
Regeneron Pharmaceuticals
Boehringer Ingelheim
Ipsen S A
EUROAPI
GlaxoSmithKline PLC
Hovione
Axplora
Steroid S.p.A.
Sun Pharmaceutical
Cipla Ltd
Anuh Pharma
Symbiotec Pharmalab
GSK
Wellona Pharma
List of Tables
 Table 1. Global Trigger Point Injections Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Local Anesthetics
 Table 3. Key Players of Corticosteroids
 Table 4. Key Players of Botulinum Toxin (Botox)
 Table 5. Key Players of Platelet-Rich Plasma (PRP)
 Table 6. Key Players of Other Agents
 Table 7. Global Trigger Point Injections Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Trigger Point Injections Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Trigger Point Injections Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Trigger Point Injections Drugs Market Share by Region (2020-2025)
 Table 11. Global Trigger Point Injections Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Trigger Point Injections Drugs Market Share by Region (2026-2031)
 Table 13. Trigger Point Injections Drugs Market Trends
 Table 14. Trigger Point Injections Drugs Market Drivers
 Table 15. Trigger Point Injections Drugs Market Challenges
 Table 16. Trigger Point Injections Drugs Market Restraints
 Table 17. Global Trigger Point Injections Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Trigger Point Injections Drugs Market Share by Players (2020-2025)
 Table 19. Global Top Trigger Point Injections Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trigger Point Injections Drugs as of 2024)
 Table 20. Ranking of Global Top Trigger Point Injections Drugs Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Trigger Point Injections Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Trigger Point Injections Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Trigger Point Injections Drugs, Product and Application
 Table 24. Global Key Players of Trigger Point Injections Drugs, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Trigger Point Injections Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Trigger Point Injections Drugs Revenue Market Share by Type (2020-2025)
 Table 28. Global Trigger Point Injections Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Trigger Point Injections Drugs Revenue Market Share by Type (2026-2031)
 Table 30. Global Trigger Point Injections Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Trigger Point Injections Drugs Revenue Market Share by Application (2020-2025)
 Table 32. Global Trigger Point Injections Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Trigger Point Injections Drugs Revenue Market Share by Application (2026-2031)
 Table 34. North America Trigger Point Injections Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Trigger Point Injections Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Trigger Point Injections Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Trigger Point Injections Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Trigger Point Injections Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Trigger Point Injections Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Trigger Point Injections Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Trigger Point Injections Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Trigger Point Injections Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Trigger Point Injections Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Trigger Point Injections Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Trigger Point Injections Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Trigger Point Injections Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Allergan Company Details
 Table 50. Allergan Business Overview
 Table 51. Allergan Trigger Point Injections Drugs Product
 Table 52. Allergan Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 53. Allergan Recent Development
 Table 54. Pfizer Company Details
 Table 55. Pfizer Business Overview
 Table 56. Pfizer Trigger Point Injections Drugs Product
 Table 57. Pfizer Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 58. Pfizer Recent Development
 Table 59. Hospira Company Details
 Table 60. Hospira Business Overview
 Table 61. Hospira Trigger Point Injections Drugs Product
 Table 62. Hospira Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 63. Hospira Recent Development
 Table 64. Mylan Company Details
 Table 65. Mylan Business Overview
 Table 66. Mylan Trigger Point Injections Drugs Product
 Table 67. Mylan Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 68. Mylan Recent Development
 Table 69. Bayer Company Details
 Table 70. Bayer Business Overview
 Table 71. Bayer Trigger Point Injections Drugs Product
 Table 72. Bayer Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 73. Bayer Recent Development
 Table 74. Zimmer Biomet Company Details
 Table 75. Zimmer Biomet Business Overview
 Table 76. Zimmer Biomet Trigger Point Injections Drugs Product
 Table 77. Zimmer Biomet Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 78. Zimmer Biomet Recent Development
 Table 79. Teva Pharmaceuticals Company Details
 Table 80. Teva Pharmaceuticals Business Overview
 Table 81. Teva Pharmaceuticals Trigger Point Injections Drugs Product
 Table 82. Teva Pharmaceuticals Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 83. Teva Pharmaceuticals Recent Development
 Table 84. Bristol Myers Squibb Company Details
 Table 85. Bristol Myers Squibb Business Overview
 Table 86. Bristol Myers Squibb Trigger Point Injections Drugs Product
 Table 87. Bristol Myers Squibb Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 88. Bristol Myers Squibb Recent Development
 Table 89. Regeneron Pharmaceuticals Company Details
 Table 90. Regeneron Pharmaceuticals Business Overview
 Table 91. Regeneron Pharmaceuticals Trigger Point Injections Drugs Product
 Table 92. Regeneron Pharmaceuticals Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 93. Regeneron Pharmaceuticals Recent Development
 Table 94. Boehringer Ingelheim Company Details
 Table 95. Boehringer Ingelheim Business Overview
 Table 96. Boehringer Ingelheim Trigger Point Injections Drugs Product
 Table 97. Boehringer Ingelheim Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 98. Boehringer Ingelheim Recent Development
 Table 99. Ipsen Company Details
 Table 100. Ipsen Business Overview
 Table 101. Ipsen Trigger Point Injections Drugs Product
 Table 102. Ipsen Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 103. Ipsen Recent Development
 Table 104. EUROAPI Company Details
 Table 105. EUROAPI Business Overview
 Table 106. EUROAPI Trigger Point Injections Drugs Product
 Table 107. EUROAPI Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 108. EUROAPI Recent Development
 Table 109. GlaxoSmithKline Company Details
 Table 110. GlaxoSmithKline Business Overview
 Table 111. GlaxoSmithKline Trigger Point Injections Drugs Product
 Table 112. GlaxoSmithKline Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 113. GlaxoSmithKline Recent Development
 Table 114. Hovione Company Details
 Table 115. Hovione Business Overview
 Table 116. Hovione Trigger Point Injections Drugs Product
 Table 117. Hovione Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 118. Hovione Recent Development
 Table 119. Axplora Company Details
 Table 120. Axplora Business Overview
 Table 121. Axplora Trigger Point Injections Drugs Product
 Table 122. Axplora Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 123. Axplora Recent Development
 Table 124. Steroid Company Details
 Table 125. Steroid Business Overview
 Table 126. Steroid Trigger Point Injections Drugs Product
 Table 127. Steroid Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 128. Steroid Recent Development
 Table 129. Sun Pharmaceutical Company Details
 Table 130. Sun Pharmaceutical Business Overview
 Table 131. Sun Pharmaceutical Trigger Point Injections Drugs Product
 Table 132. Sun Pharmaceutical Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 133. Sun Pharmaceutical Recent Development
 Table 134. Cipla Company Details
 Table 135. Cipla Business Overview
 Table 136. Cipla Trigger Point Injections Drugs Product
 Table 137. Cipla Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 138. Cipla Recent Development
 Table 139. Anuh Pharma Company Details
 Table 140. Anuh Pharma Business Overview
 Table 141. Anuh Pharma Trigger Point Injections Drugs Product
 Table 142. Anuh Pharma Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 143. Anuh Pharma Recent Development
 Table 144. Symbiotec Pharmalab Company Details
 Table 145. Symbiotec Pharmalab Business Overview
 Table 146. Symbiotec Pharmalab Trigger Point Injections Drugs Product
 Table 147. Symbiotec Pharmalab Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 148. Symbiotec Pharmalab Recent Development
 Table 149. GSK Company Details
 Table 150. GSK Business Overview
 Table 151. GSK Trigger Point Injections Drugs Product
 Table 152. GSK Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 153. GSK Recent Development
 Table 154. Wellona Pharma Company Details
 Table 155. Wellona Pharma Business Overview
 Table 156. Wellona Pharma Trigger Point Injections Drugs Product
 Table 157. Wellona Pharma Revenue in Trigger Point Injections Drugs Business (2020-2025) & (US$ Million)
 Table 158. Wellona Pharma Recent Development
 Table 159. Research Programs/Design for This Report
 Table 160. Key Data Information from Secondary Sources
 Table 161. Key Data Information from Primary Sources
 Table 162. Authors List of This Report


List of Figures
 Figure 1. Trigger Point Injections Drugs Picture
 Figure 2. Global Trigger Point Injections Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Trigger Point Injections Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Local Anesthetics Features
 Figure 5. Corticosteroids Features
 Figure 6. Botulinum Toxin (Botox) Features
 Figure 7. Platelet-Rich Plasma (PRP) Features
 Figure 8. Other Agents Features
 Figure 9. Global Trigger Point Injections Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Trigger Point Injections Drugs Market Share by Application: 2024 VS 2031
 Figure 11. Surgical Case Studies
 Figure 12. Intensive Care Area (ICU) Case Studies
 Figure 13. Medical Diagnosis Case Studies
 Figure 14. Trigger Point Injections Drugs Report Years Considered
 Figure 15. Global Trigger Point Injections Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Trigger Point Injections Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Trigger Point Injections Drugs Market Share by Region: 2024 VS 2031
 Figure 18. Global Trigger Point Injections Drugs Market Share by Players in 2024
 Figure 19. Global Trigger Point Injections Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Trigger Point Injections Drugs Revenue in 2024
 Figure 21. North America Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Trigger Point Injections Drugs Market Share by Country (2020-2031)
 Figure 23. United States Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Trigger Point Injections Drugs Market Share by Country (2020-2031)
 Figure 27. Germany Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Trigger Point Injections Drugs Market Share by Region (2020-2031)
 Figure 35. China Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Trigger Point Injections Drugs Market Share by Country (2020-2031)
 Figure 43. Mexico Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Trigger Point Injections Drugs Market Share by Country (2020-2031)
 Figure 47. Turkey Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Trigger Point Injections Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Allergan Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 52. Hospira Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 53. Mylan Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 54. Bayer Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 55. Zimmer Biomet Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 57. Bristol Myers Squibb Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 59. Boehringer Ingelheim Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 60. Ipsen Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 61. EUROAPI Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 62. GlaxoSmithKline Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 63. Hovione Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 64. Axplora Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 65. Steroid Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 66. Sun Pharmaceutical Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 67. Cipla Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 68. Anuh Pharma Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 69. Symbiotec Pharmalab Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 70. GSK Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 71. Wellona Pharma Revenue Growth Rate in Trigger Point Injections Drugs Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions